Incidence and Cancer Morbidity of Xeroderma Pigmentosum: A Swedish Population‐Based Register Study
American Journal of Medical Genetics Part A · 11.11.2026
DOI: 10.1002/ajmg.a.70359 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Medical Genetics Part A, online erschienen am 11.11.2026. Verfasst von Theofanis Zagoras und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Göteborgs Universitet, Västra Götalandsregionen, Sahlgrenska Universitetssjukhuset.
Abstract (Originalsprache)
Xeroderma pigmentosum (XP) is a rare autosomal recessive condition associated with an extreme sensitivity to ultraviolet radiation. The XP incidence and cancer risk have been estimated in clinical cohorts but no population‐based analyses are available. We used the Swedish National Patient Register and the Swedish Cancer Register to estimate the incidence of XP and the standardized incidence ratios (SIRs) for cancers over 2001–2019. A total of 24 individuals with an XP diagnosis of Q82.1 met the inclusion criteria for the study, corresponding to an estimated birth incidence of 0.72/100,000 (1/138,984). Thirty‐one cancers other than basal cell carcinomas (BCCs) were observed in six patients (SIR 20.5, 95% CI: 14.0–29.1). The SIR in males was higher compared to females ( p = 0.001). The cumulative risk for melanoma or cutaneous squamous cell carcinoma (cSCC) was 69% by the age of 80. BCC was observed in all individuals with follow‐up beyond the age of 50. While a noteworthy risk increase of cancer in individuals with XP was confirmed, the cancer incidences for melanoma, cSCC and BCC were lower compared to previous reports. The penetrance for melanoma and cSCC was incomplete at the age of 80 pointing to the possible effects of successful sun protection.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- Department of Clinical Genetics and Genomics, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.
- Institute of Biomedicine, University of Turku, Turku, Finland.
- Department of Dermatology and Venereology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.
- Center for Digital Health, Sahlgrenska University Hospital, Gothenburg, Sweden.
- Department of Dermatology and Allergology, University of Helsinki, Helsinki, Finland.
ORCID-Profile: Theofanis Zagoras, Roope A Kallionpää, Sam Polesie, Sirkku Peltonen
Förderung
- Göteborgs Universitet
- Västra Götalandsregionen
- Sahlgrenska Universitetssjukhuset
- HudFonden
Zitieren
APA
Zagoras, T., Kallionpää, R. A., Polesie, S., & Peltonen, S. (2026). Incidence and Cancer Morbidity of Xeroderma Pigmentosum: A Swedish Population‐Based Register Study. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.70359
Vancouver
Zagoras T, Kallionpää RA, Polesie S, Peltonen S. Incidence and Cancer Morbidity of Xeroderma Pigmentosum: A Swedish Population‐Based Register Study. American Journal of Medical Genetics Part A. 2026. doi:10.1002/ajmg.a.70359
BibTeX
@article{Zagoras2026,
author = {Zagoras, Theofanis and Kallionpää, Roope A and Polesie, Sam and Peltonen, Sirkku},
title = {Incidence and Cancer Morbidity of Xeroderma Pigmentosum: A Swedish Population‐Based Register Study},
journal = {American Journal of Medical Genetics Part A},
year = {2026},
doi = {10.1002/ajmg.a.70359}
}
EUVIMED